Tyler Hitchman has significant experience in the field of biomedical sciences, currently serving as the Scientific Lead in Discovery Biology at Eli Lilly and Company since January 2023. Prior to this role, Tyler worked as a Scientist at Loxo Oncology at Lilly from July 2021 to January 2023 and completed a Postdoctoral Research Fellowship at Memorial Sloan Kettering Cancer Center from March 2021 to July 2021. Tyler's academic background includes a PhD from the Gerstner Sloan-Kettering Graduate School of Biomedical Sciences, earned between 2016 and 2021, and a Bachelor of Science in Biomolecular Science from Clarkson University, completed in 2015.
This person is not in the org chart
This person is not in any teams
This person is not in any offices